The increase in CCL-5 levels in patients who presented hypofibrinogenemia may be associated with a possible action of the generated thrombin and FXa, since these factors are responsible for the expression of this chemokine in fibroblasts, platelets, and endothelial cells (76–78). The gene discussed is F10; the disease is Hypofibrinogenemia.